Cellebrite DI Ltd. officer Marcus Jewell filed a Form 144 notice on November 17, 2026, disclosing a proposed sale of 9,928 common shares with an aggregate market value of $110,399.36 on NASDAQ.
Key Highlights
- Proposed sale: Marcus Jewell, an officer of Cellebrite DI Ltd., intends to sell 9,928 common shares with an aggregate market value of $110,399.36.
- Source of shares: According to the filing, the securities were acquired through restricted stock unit vesting between August 11, 2026 and November 15, 2026, with the specific lot of 9,928 shares acquired on August 11, 2026.
- Broker: The proposed sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.
- 10b5-1 plan: The filing indicates a Rule 10b5-1 plan adoption date of August 14, 2026.
- Prior sales in past 3 months: Jewell sold 12,462 shares on November 16, 2026 for gross proceeds of $143,963.52; 393 shares on November 12, 2026 for $5,230.95; and 12,562 shares on August 21, 2026 for $141,216.98.
- Shares outstanding: The filing reports 251,341,060 common shares outstanding at the time of the notice.
Jewell's Proposed Sale and Recent Transaction History at Cellebrite
According to the Form 144 notice filed with the SEC on November 17, 2026, Marcus Jewell, identified as an officer of Cellebrite DI Ltd. (NASDAQ:CLBT), proposed to sell 9,928 common shares at an aggregate market value of $110,399.36. The shares to be sold were acquired on August 11, 2026 via restricted stock unit vesting from the issuer, with payment recorded on the same date. The filing states that "the securities to be sold were acquired upon the vesting of restricted stock units during the period of 08/11/2026 through 11/15/2026."
The filing also discloses Jewell's sales activity during the three months preceding the notice. On November 16, 2026, Jewell sold 12,462 shares for gross proceeds of $143,963.52. On November 12, 2026, an additional 393 shares were sold for $5,230.95. Earlier, on August 21, 2026, Jewell sold 12,562 shares for gross proceeds of $141,216.98. All sales listed the seller's address as 94 Shlomo Shmelzer Road, Petah Tikva, Israel.
The notice was filed with an approximate sale date of November 17, 2026, and identifies Cellebrite's total common shares outstanding as 251,341,060. The filing indicates that Jewell is relying on a Rule 10b5-1 plan or trading instruction adopted on August 14, 2026. By signing the notice, the filer represented having no knowledge of material adverse information regarding Cellebrite's current and prospective operations that has not been publicly disclosed.
What Was Disclosed
Cellebrite DI Ltd. officer Marcus Jewell filed a Form 144 on November 17, 2026, giving notice of a proposed sale of 9,928 common shares valued at $110,399.36, acquired through restricted stock unit vesting, under a Rule 10b5-1 plan adopted August 14, 2026.




Please wait processing your request...